Collectively, these data from cell and animal models or clinical specimens demonstrate that SREBP-1 plays a very important role in prostate cancer progression and that multiple signaling pathways, such as AR and miRNAs, can regulate SREBP-1 activation to mediate the dysfunction of lipid metabolism in prostate cancer. The gene discussed is SREBF1; the disease is prostate carcinoma.